Viking Therapeutics
VKTX
#3346
Rank
โ‚ฌ3.62 B
Marketcap
32,06ย โ‚ฌ
Share price
-1.84%
Change (1 day)
-32.73%
Change (1 year)

Revenue for Viking Therapeutics (VKTX)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viking Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.54 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ64.8 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.60 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA